243 related articles for article (PubMed ID: 23850868)
21. Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.
Liang W; Zhou G; Liu W; Yang B; Li C; Wang H; Yang D; Ma W; Yu L
Arch Virol; 2016 Oct; 161(10):2705-16. PubMed ID: 27422396
[TBL] [Abstract][Full Text] [Related]
22. Characterization of foot-and-mouth disease serotype asial viruses grown in the presence of polyclonal antisera in serology and nucleotide sequence analysis.
Kumar RM; Sanyal A; Hemadri D; Tosh C; Mohapatra JK; Bandyopadhyay SK
Arch Virol; 2004 Sep; 149(9):1801-14. PubMed ID: 15593421
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
25. Neutralizing monoclonal antibodies against porcinophilic foot-and-mouth disease virus mapped to antigenic site 2 by utilizing novel mutagenic virus-like particles to detect the antigenic change.
Lee HW; Deng MC; Pan CH; Chang HW; Cheng IC
Vet Microbiol; 2018 Aug; 222():124-131. PubMed ID: 30080667
[TBL] [Abstract][Full Text] [Related]
26. Mapping of antigenic sites of foot-and-mouth disease virus serotype Asia 1 and relationships with sites described in other serotypes.
Grazioli S; Fallacara F; Brocchi E
J Gen Virol; 2013 Mar; 94(Pt 3):559-569. PubMed ID: 23197575
[TBL] [Abstract][Full Text] [Related]
27. Differential antibody responses to the major antigenic sites of FMD virus serotype O after primo-vaccination, multiply-vaccination and after natural exposure.
Biswal JK; Subramaniam S; Ranjan R; VanderWaal K; Sanyal A; Pattnaik B; Singh RK
Infect Genet Evol; 2020 Mar; 78():104105. PubMed ID: 31706082
[TBL] [Abstract][Full Text] [Related]
28. Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 G-H loop as a new tool for studying FMDV pathogenesis.
Lawrence P; Pacheco JM; Uddowla S; Hollister J; Kotecha A; Fry E; Rieder E
Virology; 2013 Feb; 436(1):150-61. PubMed ID: 23228860
[TBL] [Abstract][Full Text] [Related]
29. A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide.
Wang JL; Liu MQ; Han J; Chen WZ; Cong W; Cheng G; Gao YH; Lu YG; Chen JL; Zuo XP; Yan WY; Zheng ZX
Vet Microbiol; 2007 Dec; 125(3-4):224-31. PubMed ID: 17656048
[TBL] [Abstract][Full Text] [Related]
30. Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain.
Baranowski E; Ruiz-Jarabo CM; Lim F; Domingo E
Virology; 2001 Sep; 288(2):192-202. PubMed ID: 11601891
[TBL] [Abstract][Full Text] [Related]
31. Identification of a conserved linear epitope on the VP1 protein of serotype O foot-and-mouth disease virus by neutralising monoclonal antibody 8E8.
Yang D; Zhang C; Zhao L; Zhou G; Wang H; Yu L
Virus Res; 2011 Jan; 155(1):291-9. PubMed ID: 20974198
[TBL] [Abstract][Full Text] [Related]
32. Genetic and antigenic analysis of two recently circulating genotypes of type A foot-and-mouth disease virus in India: evidence for positive selection in the capsid-coding genes.
Tosh C; Hemadri D; Sanyal A; Bandyopadhyay SK
Arch Virol; 2003 May; 148(5):853-69. PubMed ID: 12721795
[TBL] [Abstract][Full Text] [Related]
33. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
Fowler VL; Knowles NJ; Paton DJ; Barnett PV
Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel epitopes in serotype O foot-and-mouth disease virus by in vitro immune selection.
Mahapatra M; Upadhyaya S; Parida S
J Gen Virol; 2019 May; 100(5):804-811. PubMed ID: 30990405
[TBL] [Abstract][Full Text] [Related]
35. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine.
Fernandez-Sainz I; Gavitt TD; Koster M; Ramirez-Medina E; Rodriguez YY; Wu P; Silbart LK; de Los Santos T; Szczepanek SM
Vaccine; 2019 Jun; 37(26):3435-3442. PubMed ID: 31085001
[TBL] [Abstract][Full Text] [Related]
36. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
[TBL] [Abstract][Full Text] [Related]
37. Serotype-specific differences in antigenic regions of foot-and-mouth disease virus (FMDV): a comprehensive statistical analysis.
Cooke JN; Westover KM
Infect Genet Evol; 2008 Dec; 8(6):855-63. PubMed ID: 18790086
[TBL] [Abstract][Full Text] [Related]
38. Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African Territories types using virus neutralization data.
Maree FF; Blignaut B; Esterhuysen JJ; de Beer TAP; Theron J; O'Neill HG; Rieder E
J Gen Virol; 2011 Oct; 92(Pt 10):2297-2309. PubMed ID: 21697350
[TBL] [Abstract][Full Text] [Related]
39. Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment.
Martín V; Perales C; Abia D; Ortíz AR; Domingo E; Briones C
BMC Genomics; 2006 May; 7():117. PubMed ID: 16709242
[TBL] [Abstract][Full Text] [Related]
40. Genetic and antigenic characterization of Indian foot-and-mouth disease virus serotype O isolates collected during the period 2001 to 2012.
Yuvaraj S; Madhanmohan M; Nagendrakumar SB; Kumar R; Subramanian BM; Mohapatra JK; Sanyal A; Pattnaik B; Srinivasan VA
Infect Genet Evol; 2013 Jan; 13():109-15. PubMed ID: 23123825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
